Dysautonomia and neurocardiogenic syncope.
Syncope in childhood is a common problem. In most children, syncope is benign, secondary to a disturbance in autonomic control of heart rate and blood pressure. It is increasingly evident that neurally mediated syncope is a heterogeneous group of conditions, necessitating a reclassification of autonomic disorders. New entities, such as postural orthostatic tachycardia and cerebral vasoconstrictive syncope, are recognized. The key to the diagnosis of syncope is a careful history. Tilt testing can be useful when the history is unclear. Unfortunately tilt test protocols vary, affecting specificity and sensitivity. The mainstay of therapy is reassurance. If symptoms are troublesome, Fludrocortisone and B-blockers remain the favored drugs. The efficacy of Midodrine and Serotonin Uptake Inhibitors is currently under review. Cardiac pacing is effective for those patients with severe episodes and demonstrated asystole. It is not known whether pacing would be effective for the majority who have neurally mediated syncope without significant bradycardia.
Department of Cardiology, Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow, UK. karen.mcleod@yorkhill.scot.nhs.uk
K A
KA
McLeod
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001342:Autonomic Nervous System Diseases / Q000175:diagnosis* / Q000628:therapy; D002304:Cardiac Pacing, Artificial; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004562:Electrocardiography; D005438:Fludrocortisone / Q000627:therapeutic use; D006801:Humans; D008901:Mineralocorticoids / Q000627:therapeutic use; D012008:Recurrence; D019462:Syncope, Vasovagal / Q000175:diagnosis* / Q000628:therapy; D018667:Tilt-Table Test
D000319:Adrenergic beta-Antagonists; D008901:Mineralocorticoids; D005438:Fludrocortisone